Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Smokers smoking at least 15 cigarettes/day as a mean within the 2 months preceding the screening visit~* Motivated to quit with a score greater than or equal to 6 on the ten-point Motivation Scale~Exclusion Criteria:~* non tobacco cigarettes consumption~* chronic use of marijuana~* pregnancy~* breastfeeding~* any clinically significant disease that might interfere with the efficacy or safety evaluation of the study drug~* Concomitant use of drugs as an aid to smoking cessation or that might induce weight change

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).